On February 10, 2026, Shenzhen Zeroth AI Technology Co., Ltd., an AI company founded just over five years ago, formally submitted its listing application to the Hong Kong Stock Exchange, with CMBC Capital as the exclusive sponsor. According to Frost & Sullivan, by revenue in 2024, Zeroth AI has become the fifth-largest provider of enterprise-grade AI agent solutions in China, with a market share of 3.0%. Centered on its self-developed “BlackZero” platform and focused on AI assistants for contract and investment scenarios, the young company has stepped into the capital market with its net profit tripled over three years.
February 11, 2026, NETEASE MUSIC(09899.HK) released its Annual Report for the period ended December 31, 2025, Total Revenue stood at CNY 7.76 billion, decreased by 2.4% YoY
NewTimeSpace News, according to an announcement disclosed on the Singapore Exchange on February 10, Japan's Takeda Pharmaceutical announced that its New Drug Application (NDA) for Oveporexton (TAK-861), a potential first-in-class therapy developed by the company, has been accepted by the U.S. Food and Drug Administration (FDA) and granted priority review status for the treatment of Narcolepsy Type 1 (NT1).
NewTimeSpace News,Singapore-listed enterprise Ever Glory United released an announcement on February 6 stating that it had secured new contracts with a total value of S$508 million in 2025, pushing the Group’s total order book up to S$732.8 million as of December 31, 2025. The new contracts cover high-value sectors including healthcare, hospitality and public infrastructure.
Vitalink Technology Co., Ltd., the world's largest provider of PVD interface enhancement solutions for consumer electronics, formally submitted an IPO application to the HKEX on February 9. The company is deeply bound to giants such as Apple and Samsung, with revenue surging 49.3% in 2024. However, its top two customers account for over 70% of revenue, representing high customer concentration as the major risk. To mitigate such risk, the company's smart wearable business has grown rapidly and become a high-margin growth engine. Moving forward, the company needs to seize opportunities from AI hardware innovation, reduce customer dependency, and successfully expand its technology into new sectors such as smart vehicles.
NewTimeSpace News, CGS announced on February 9 the successful issuance of the 4th Tranche of Short-Term Financing Bonds in 2026, with an issuance scale of RMB 4 billion and a final coupon rate of 1.67%. All the funds raised will be used exclusively to supplement the company's working capital.
NewTimeSpace News, CHINA WATER announced on February 9 that its wholly-owned subsidiary Yinlong has entered into a framework agreement with the joint venture company to renew the continuing connected transactions. The joint venture company will supply equipment and services related to pipeline direct drinking water to China Water Affairs Group from April 1, 2026 to March 31, 2029, with an annual transaction cap of RMB 40 million for each year.
NewTimeSpace News, ELATE HOLDINGS announced on February 6 that it has signed a three-year cooperation and management agreement with Aomi Company, a leading local lifestyle e-commerce platform in Macau. Under the agreement, Elate Holdings will assist Aomi Company in expanding into Asian markets, participating in internal management, and introducing artificial intelligence technology. The two parties will subsequently sign a further agreement to clarify details regarding management fees and profit-sharing.
NewTimeSpace News, SKB BIO-B announced on February 6 that its core product TROP2 ADC sacituzumab govitecan (sac-TMT) has obtained approval from the National Medical Products Administration (NMPA) for the launch of its fourth indication, targeting the treatment of a specific type of HR+/HER2- breast cancer.
NewTimeSpace News,ZHONGTAIFUTURES issued a profit forecast announcement on February 5. Based on preliminary assessment, the company's net profit attributable to shareholders in 2025 is expected to increase by approximately 1,677% compared with the same period in 2024. The projected performance growth is mainly driven by the company's efforts in improving operational quality and efficiency, as well as the low base in the corresponding period of 2024.
NewTimeSpace News, HENLIUS announced via a notice on February 4 that it has completed the relevant matters regarding H-share full circulation. A total of 182.6459 million unlisted shares have been converted to H-shares, and these converted H-shares will be listed on the Hong Kong Exchanges and Clearing Limited (HKEX) at 9:00 a.m. on February 5, 2026.
NewTimeSpace News, CITIC BANK announced on February 4 that it intends to inject RMB2 billion in cash into its wholly-owned subsidiary CITIC Financial Leasing Co., Ltd. (CITIC Financial Leasing) using its own funds. After the capital increase, the registered capital of CITIC Financial Leasing will be increased to RMB12 billion.
NewTimeSpace News,CHINA SCE GROUP announced on February 3 that its 6% senior notes maturing in 2026 will fall due on February 4. Due to tight liquidity, the group expects to be unable to repay the outstanding principal of US$350 million and accrued but unpaid interest when the notes mature. The notes will be delisted from the Stock Exchange of Hong Kong (SEHK) after their maturity date.
As a global leader in lithium battery equipment, Wuxi LEAD Intelligent Equipment Co., Ltd. is set to list on the HKEX on February 11. The company specializes in providing high-end smart equipment and turnkey line solutions for the lithium battery, photovoltaic, 3C manufacturing and other industries, and ranks first in the global market share for lithium battery equipment in particular. However, affected by cyclical fluctuations in the downstream industry, the company's performance has seen a significant decline in recent years, with its cash flow and inventory management facing severe challenges. This renders its listing journey a combination of the advantages of an industry leader and notable operational risks.
NewTimeSpace News,UNI MEDICAL announced on February 2 that its wholly-owned subsidiary, China Universal Leasing Co., Ltd., has obtained approval from the China Securities Regulatory Commission (CSRC) to publicly issue the first tranche of corporate bonds in 2026. The issuance scale will not exceed RMB1 billion, with a base term of 5 years and an AAA issuer credit rating. The offline issuance is scheduled to start on February 3.
NewTimeSpace News,BLUE RIVER HLDG announced on February 2 that it has signed a cooperation framework agreement with Wuhan Energy Storage & Operation Investment Co., Ltd. Both parties will explore cooperation in areas including the construction and operation of LNG storage facilities, undertaking the "Marine Gas Inflow to Rivers" project, and coal trading.
